ARCHIVES

In Brief: Senate Sets NCI rescission At $14 Million Baltimore Program Conversation To Cancer Center Will Be asked

This article is from The Cancer Letter archive.

Vol. 07 No. 20 | May 15, 1981

Download PDF Visit The Full Archive

Related Articles

Bioassay Backlog To Be Cleared Up In Year: Squire

November 26, 1976

In Brief: Hazleton Acquires Prime Labs, Primate Importer; Cullen UCLA Deputy Director

July 30, 1976

NIH Signs Agreement For Use Of Five Stem Cell Lines.

September 7, 2001

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

December 19, 2014

NTP Committee Finds Five Test Reports Show “Limited” Evidence Of Carcinogenicity

February 27, 1981

MD Anderson Researcher Charged With Placing Ethylene Glycol In Colleague’s Coffee

June 14, 2013